Loading clinical trials...
Loading clinical trials...
A prospective assessment of the impact of Omalizumab in terms of efficacy, safety, and quality of life (FA-QoL) in patients with moderate/severe asthma and history of anaphylaxis to peanut, tree nuts,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bambino Gesù Hospital and Research Institute
NCT07011394 · Diagnosis, Inflammation, and more
NCT06003569 · Asthma in Children
NCT07412769 · Asthma Acute, Asthma Childhood, and more
NCT05667701 · Wheezing, Asthma in Children
NCT07138027 · Asthma in Children
Pediatric Hospital Bambino Gesù IRCCS - Allergy Dpt
Roma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions